ADRB2 rs1042711: Understanding This Genetic Variant
The rs1042711 variant is a common genetic polymorphism located within the ADRB2 gene. It is primarily studied for its potential influence on the function of beta-2 adrenergic receptors, which play a role in regulating physiological responses like heart rate and blood pressure.
What each genotype means
Typical receptor response
This genotype is considered the common or reference form of this variant. Research into this specific site (often noted as -47C/T) has generally classified it as benign in clinical databases. Please consult with your healthcare provider regarding any specific concerns about your medication response or fitness profile.
This is the most common genotype observed across most global populations.
Common variant carrier
Carrying one copy of the T allele is a common genetic variation. While some variants in the ADRB2 gene are linked to medication response, this specific site is generally classified as benign in clinical literature. Always discuss any changes to your health or medication regimen with your clinician or pharmacist.
This genotype is found at varying frequencies across different ancestral groups, representing a common variation in the human population.
Common variant homozygote
Carrying two copies of the T allele is a known variation for this genetic location. Current clinical databases classify this variant as benign, meaning it is not typically associated with significant health risks or altered drug responses. Please discuss any questions regarding your health or medication management with your healthcare provider.
This genotype is present in a portion of the population, though it is less common than the CC genotype in many ancestral groups.
What is rs1042711 and Where is it Located?
The rs1042711 variant is a single nucleotide polymorphism (SNP) found on chromosome 5. In the human genome, it is positioned at 148,826,785 (GRCh38). This specific location places it within the ADRB2 gene, which encodes the beta-2 adrenergic receptor. SNPs are the most common type of genetic variation among people, representing a difference in a single DNA building block, or nucleotide. While many SNPs have no effect on health or physical traits, researchers track them to understand how variations in our genetic code might contribute to differences in biological function or susceptibility to certain conditions. Because rs1042711 is located in a gene responsible for critical signaling pathways, it has been the subject of various studies investigating its potential impact on human physiology.
The Role of the ADRB2 Gene
The ADRB2 gene provides instructions for making the beta-2 adrenergic receptor. This protein is found on the surface of many cell types, including those in the smooth muscles of the airways, blood vessels, and the heart. These receptors are part of the sympathetic nervous system and are activated by catecholamines like epinephrine and norepinephrine. When these molecules bind to the receptor, they trigger a cascade of signals that can lead to the relaxation of smooth muscles, the dilation of airways, and changes in heart rate and blood pressure. Because of its central role in these processes, the ADRB2 gene is frequently studied in the context of respiratory health, cardiovascular function, and exercise physiology. Variations in this gene may theoretically alter how these receptors are expressed or how effectively they respond to internal and external signals.
Research Associations and Evidence Strength
Research into rs1042711 has explored its potential associations with various health outcomes, including asthma susceptibility and responses to certain medications. However, the evidence strength for this specific variant is considered moderate. While some studies have investigated its role in exercise-induced physiological changes, results across different populations have been mixed. It is important to note that many associations identified in genetic research are statistical in nature and do not imply a direct cause-and-effect relationship. Furthermore, complex traits like heart rate response or asthma are influenced by a combination of many genetic variants, environmental factors, and lifestyle choices. Because the findings are often inconsistent or limited to specific study groups, the clinical significance of rs1042711 remains a subject of ongoing scientific inquiry rather than a definitive diagnostic marker.
Population Frequency
The rs1042711 variant is a well-documented polymorphism, and its frequency varies across different global populations. It has been reclassified in some databases as a common polymorphism rather than a rare disease-causing mutation, reflecting its prevalence in the general population.
What You Can and Cannot Do With This Information
Understanding your genetic variants can be an educational experience, but it is vital to maintain realistic expectations. You cannot use information about rs1042711 to diagnose yourself with a medical condition or to predict your exact physical performance. Genetic data is only one piece of a much larger puzzle that includes your environment, diet, and overall health history. If you are interested in how your genetics might influence your response to specific medications, such as beta-agonists, you must discuss this with your clinician or pharmacist. They are the only ones qualified to interpret your genetic information in the context of your personal health and to provide guidance on appropriate treatments. Avoid making changes to your health regimen based solely on genetic reports, as these findings are not a substitute for professional medical advice.
How common is this variant?
The rs1042711 variant is widely distributed, with frequencies that differ significantly by ancestry. It is considered a common polymorphism in human populations.
Frequently asked questions
Is rs1042711 a disease-causing mutation?
No, rs1042711 is classified as a common polymorphism. It is a natural variation in the human genome and is not considered a mutation that causes a specific disease.
Can this variant predict my athletic performance?
There is no scientific evidence that rs1042711 can reliably predict athletic performance. While some studies look at its role in exercise physiology, athletic ability is a complex trait influenced by many genes and environmental factors.
Should I change my medication based on this SNP?
Absolutely not. You should never change your medication or dosage based on genetic test results without consulting your doctor or pharmacist. They can evaluate your specific health needs and determine if any adjustments are necessary.
Where can I find more information about ADRB2?
You can find reliable information about the ADRB2 gene on resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive, peer-reviewed summaries of gene functions and associated research.
Sources & further reading
Educational information only, last refreshed 10/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1042711?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADRB2
Variant in the beta-2 adrenergic receptor linked to metabolic regulation, exercise-induced lipolysis, and endurance performance.
Synonymous polymorphism in the beta-2 adrenergic receptor (Gln27Glu) modulating receptor down-regulation.
The Gln27Glu variant in the beta-2 adrenergic receptor is associated with metabolic and vascular responses to exercise.
Modulates beta-2 adrenergic receptor expression and cardiovascular reactivity.
This variant in the beta-2 adrenergic receptor gene is associated with differential responses to beta-agonist therapy in asthma patients.
Functional variant in the beta-2 adrenergic receptor linked to metabolic rate and cardiovascular reactivity.